Results 231 to 240 of about 213,774 (293)
Interventional oncology in children: Where are we now?
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel +1 more
wiley +1 more source
Molecular guided therapy leading to exceptional response in relapsed osteosarcoma. [PDF]
Wert E +8 more
europepmc +1 more source
ABSTRACT This report describes a rare case of alveolar rhabdomyosarcoma initially presenting with clinical features resembling an endodontic lesion. A 15‐year‐old male presented with progressive right maxillary swelling initially treated as a dental abscess.
Saliha Akçay Köprücü +3 more
wiley +1 more source
Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells. [PDF]
Chen JY, Wang GS, Chang TM, Liu JF.
europepmc +1 more source
ABSTRACT This in vitro study evaluated the effects of intracanal medications on the metabolic activity and adhesion of human periodontal ligament‐derived mesenchymal stem cells. Tested groups included Control (without medication), Triple Antibiotic Paste (TAP), Double Antibiotic Paste (DAP), calcium hydroxide with saline, calcium hydroxide with 2 ...
Arian Braido +7 more
wiley +1 more source
Histological prognostic factors in canine appendicular osteosarcoma: 57 cases (2014-2022). [PDF]
Miyagi H +6 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
AVIL promotes osteosarcoma progression and cisplatin resistance via ARP2/3-mediated DNA damage repair. [PDF]
Chen Z +9 more
europepmc +1 more source
Pathway Analysis of Major Genes Affecting Osteosarcoma Metastasis
Aditi Makaram +2 more
openalex +1 more source
This study aimed to evaluate transferrin receptor (TfR) expression in human esophageal squamous cell cancer (ESCC) specimens and investigate the correlation between TfR overexpression and clinicopathological characteristics. Furthermore, we explored the potential of targeting iron metabolism pathways as a novel therapeutic strategy for ESCC.
Naoki Ikenaga +16 more
wiley +1 more source

